In traditional Asian medicinal systems, preparations of the root and stem bark of species are widely used to treat anxiety and other nervous disturbances. The biphenyl-type neolignans honokiol and magnolol are the main constituents of bark extracts. In the central nervous system, bark preparations that contain honokiol are thought to primarily interact with γ-aminobutyric acid A (GABA) receptors. However, stress responses inherently involve the noradrenergic system, which has not been investigated in the pharmacological mechanism of honokiol. We present here interactions of honokiol and other synthesized biphenyl-type neolignans and diphenylmethane analogs with the norepinephrine transporter (NET), which is responsible for the synaptic clearance of norepinephrine and the target of many anxiolytics. Of the synthesized compounds, 16 are new chemical entities, which are fully characterized. The 52 compounds tested show mild, non-potent interactions with NET (IC > 100 µM). It is thus likely that the observed anxiolytic effects of, e.g., preparations, are not due to direct interaction with the noradrenergic system.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222891 | PMC |
http://dx.doi.org/10.3390/molecules23102536 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!